Big Cons: How Consultancy Firms Undermine Governments
By Ong Kar Jin and Jomo Kwame SundaramKUALA LUMPUR, Malaysia, Dec 6 2023 (IPS) Greater government reliance on consulting companies has greatly enriched them while also undermining state capacities, capabilities, national economies, progress, governance and legitimacy.
The Big Con
Over recent decades, policy consultancy has gradually gained more public attention. With the COVID-19 pandemic, consultancies were paid billions, with meagre results, leaving even less for millions of others desperately struggling to cope.
Ong Kar JinIn The Big Con: How the Consulting Industry Weakens our Businesses, Infantilizes our Governments...
Source: IPS Inter Press Service - Health - December 6, 2023 Category: International Medicine & Public Health Authors: Ong Kar Jin and Jomo Kwame Sundaram Tags: Economy & Trade Education Financial Crisis Global Headlines Health Labour TerraViva United Nations IPS UN Bureau Source Type: news
Peter Thiel-cofounded Palantir will overhaul the U.K. ’s health service in a deal worth more than $400m
The U.K.’s National Health Service will start working with Palantir, the tech company co-founded by PayPal’s Peter Thiel, on a data overhaul following a deal worth up to £330 million (about $413 million). While that could mean a massive revamp for the U.K.’s publicly-funded healthcare system, it’s…#paypal #peterthiel #nhs #accenture #pwc #nhsengland #nhsnational #vindiwakar #palantir #parliament (Source: Reuters: Health)
Source: Reuters: Health - November 22, 2023 Category: Consumer Health News Source Type: news
CRISPR Therapy Gets U.K. Approval, the First in the World
Britain’s medicines regulator has authorized the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K.
[time-brightcove not-tgx=”true”]
In a statement on Thursday, the Medicines and Healthcare Regulatory Agency said it approved Casgevy, the first medicine licensed using the gene editing tool CRISPR, which won its makers a Nobel prize in 2020.
The agency approved the treatment for patients with sickle cell disease and thalassemia who are 12 years old and over. Casgevy is made by Vertex ...
Source: TIME: Health - November 16, 2023 Category: Consumer Health News Authors: MARIA CHENG / AP Tags: Uncategorized Drugs wire Source Type: news
Evaluation of an acute trust domestic abuse coordinator role: impact findings and a budget impact model - Melendez-Torres GJ, Crathorne L, Hepworth E, Sloane V, Jackson S, Nicholas R, Cohen CE.
Domestic Abuse Coordinators (DACs) work strategically across National Health Service (NHS) hospital and other off-site clinical settings to support clinical staff in domestic abuse enquiry and response, and to co-lead the development and implementation of ... (Source: SafetyLit)
Source: SafetyLit - November 6, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] FDA approves Roche ’s Vabysmo for the treatment of retinal vein occlusion (RVO)
RVO is the third indication for Vabysmo, in addition to neovascular or ‘wet’ age-related macular degeneration and diabetic macular edemaApproval is based on two phase III studies demonstrating early and sustained vision improvements that were non-inferior to afliberceptVabysmo also demonstrated rapid and robust drying of retinal fluidAdditional U.S. label update across indications includes information on rare post-marketing reports of retinal vasculitis and/or retinal vascular occlusion; reporting rate isin line withother broadly used intravitreal treatmentsBasel, 27 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) an...
Source: Roche Investor Update - October 27, 2023 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] FDA approves Roche ’s Vabysmo for the treatment of retinal vein occlusion (RVO)
RVO is the third indication for Vabysmo, in addition to neovascular or ‘wet’ age-related macular degeneration and diabetic macular edemaApproval is based on two phase III studies demonstrating early and sustained vision improvements that were non-inferior to afliberceptVabysmo also demonstrated rapid and robust drying of retinal fluidAdditional U.S. label update across indications includes information on rare post-marketing reports of retinal vasculitis and/or retinal vascular occlusion; reporting rate isin line withother broadly used intravitreal treatmentsBasel, 27 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) an...
Source: Roche Media News - October 27, 2023 Category: Pharmaceuticals Source Type: news
Experiences of ethnic minoritised young people in a specialist child and adolescent mental health services: a qualitative analysis as part of a mixed methods service evaluation - Sarr R.
BACKGROUND: There have been several reports of inequalities for ethnic minoritised service users across National Health Service mental health services in the United Kingdom. This research aims to explore the perspectives and experiences of young people fro... (Source: SafetyLit)
Source: SafetyLit - October 19, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
How COVID-19 Changed Life for People Terrified of Needles
From the moment COVID-19 reached pandemic designation, Joe McDougall had nightmares. Not, like others, about the potential path of the virus, but about the seemingly inevitable moment at which he’d be asked—or held down and forced—to receive a vaccine. McDougall, now 39, is terrified of needles and a global pandemic meant that for the first time since adolescence, he might not be able to avoid them.
[time-brightcove not-tgx=”true”]
Of all of the challenges facing mass COVID-19 vaccination, fear of needles is one of the least acknowledged by public-health campaigns. Even what we know ...
Source: TIME: Health - October 12, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized healthscienceclimate Source Type: news
Celebrating 75th Anniversary of the National Health Service Celebrating 75th Anniversary of the National Health Service
David J. Kerr, CBE, MD, DSc, discusses the 75th anniversary of the creation of the National Health Service.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 11, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Roche ’s Vabysmo maintained vision improvements with extended treatment intervals up to four months for people with retinal vein occlusion (RVO) in phase III studies
Vabysmo showed robust and sustained retinal drying up to 72 weeks and a safety profile consistent with previous studiesRegulatory applications for Vabysmo in RVO are under review by health authorities around the world; if approved, RVO would be the third indication in addition to nAMD and DMEVabysmo is the first and only treatment that targets and inhibits two signalling pathways linked to a number of vision-threatening retinal conditionsBasel, 10 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline long-term results from the global phase III BALATON and COMINO studies, evaluating extended tre...
Source: Roche Media News - October 10, 2023 Category: Pharmaceuticals Source Type: news
Roche ’s Vabysmo maintained vision improvements with extended treatment intervals up to four months for people with retinal vein occlusion (RVO) in phase III studies
Vabysmo showed robust and sustained retinal drying up to 72 weeks and a safety profile consistent with previous studiesRegulatory applications for Vabysmo in RVO are under review by health authorities around the world; if approved, RVO would be the third indication in addition to nAMD and DMEVabysmo is the first and only treatment that targets and inhibits two signalling pathways linked to a number of vision-threatening retinal conditionsBasel, 10 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline long-term results from the global phase III BALATON and COMINO studies, evaluating extended tre...
Source: Roche Investor Update - October 10, 2023 Category: Pharmaceuticals Source Type: news
England's National Health Service operates on holiday-level staffing as doctors' strike escalates
Britain’s state-owned health service is operating on holiday-level staffing in England as doctors in the early stages of their careers joined their more senior colleagues in their first-ever joint strike action (Source: ABC News: Health)
Source: ABC News: Health - September 20, 2023 Category: Consumer Health News Tags: Health Source Type: news
Annals of Government-Run Medicine
One of the world’s most celebrated socialized medical systems is doing what socialized medical systems do: limiting patient care. Pending work stoppages could mean that the worst is yet to come for patients of England’s National Health Service. (Source: Reuters: Health)
Source: Reuters: Health - September 19, 2023 Category: Consumer Health News Source Type: news
Sexual harassment, sexual assault and rape by colleagues in the surgical workforce, and how women and men are living different realities: observational study using NHS population-derived weights - Begeny CT, Arshad H, Cuming T, Dhariwal DK, Fisher RA, Franklin MD, Jackson PM, McLachlan GM, Searle RH, Newlands C.
BACKGROUND: This observational study, paired with National Health Service (NHS) workforce population data, examined gender differences in surgical workforce members' experiences with sexual misconduct (sexual harassment, sexual assault, rape) among colleag... (Source: SafetyLit)
Source: SafetyLit - September 16, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Wegovy weight loss drug: UK's National Health Service gets limited supply
Wegovy, manufactured by Danish pharmaceutical company Novo Nordisk, is a popular new weight loss drug. The weight loss drug Wegovy is now available for patients in the United Kingdom despite its limited supply. The drug will be prescribed to patients undergoing weight loss management treatment…#danish #novonordisk #unitedkingdom #nhs #departmentofhealth #wegovy #douglastwenefour #anaesthesia (Source: Reuters: Health)
Source: Reuters: Health - September 4, 2023 Category: Consumer Health News Source Type: news
